Back to top

rating-upgrade: Archive

Zacks Equity Research

Heron Therapeutics (HRTX) Upgraded to Buy: Here's Why

Heron Therapeutics (HRTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

HRTX

Zacks Equity Research

What Makes Cue Biopharma, Inc. (CUE) a New Strong Buy Stock

Cue Biopharma, Inc. (CUE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CUE

Zacks Equity Research

All You Need to Know About Continental (CBPX) Rating Upgrade to Buy

Continental (CBPX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CBPX

Zacks Equity Research

What Makes American Superconductor (AMSC) a New Strong Buy Stock

American Superconductor (AMSC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AMSC

Zacks Equity Research

China Automotive Systems (CAAS) Upgraded to Strong Buy: What Does It Mean for the Stock?

China Automotive Systems (CAAS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CAAS

Zacks Equity Research

Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock?

Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BNGO

Zacks Equity Research

Bloom Energy (BE) Moves to Buy: Rationale Behind the Upgrade

Bloom Energy (BE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BE

Zacks Equity Research

Atlantic Tele-Network (ATNI) Upgraded to Buy: Here's What You Should Know

Atlantic Tele-Network (ATNI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ATNI

Zacks Equity Research

Apyx (APYX) Upgraded to Buy: Here's Why

Apyx (APYX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APYX

Zacks Equity Research

American Public Education (APEI) Upgraded to Buy: What Does It Mean for the Stock?

American Public Education (APEI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APEI

Zacks Equity Research

Cable One (CABO) Upgraded to Strong Buy: Here's What You Should Know

Cable One (CABO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CABO

Zacks Equity Research

Celyad SA (CYAD) Moves to Buy: Rationale Behind the Upgrade

Celyad SA (CYAD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

CYAD

Zacks Equity Research

Green Brick Partners (GRBK) Moves to Strong Buy: Rationale Behind the Upgrade

Green Brick Partners (GRBK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

GRBK

Zacks Equity Research

Axovant (AXGT) Moves to Strong Buy: Rationale Behind the Upgrade

Axovant (AXGT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AXGT

Zacks Equity Research

What Makes IsoRay (ISR) a New Strong Buy Stock

IsoRay (ISR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ISR

Zacks Equity Research

What Makes Zovio (ZVO) a New Strong Buy Stock

Zovio (ZVO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ZVO

Zacks Equity Research

Barclays (BCS) Upgraded to Strong Buy: Here's Why

Barclays (BCS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

BCS

Zacks Equity Research

Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why

Atara Biotherapeutics (ATRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ATRA

Zacks Equity Research

All You Need to Know About Amadeus IT Group SA (AMADY) Rating Upgrade to Buy

Amadeus IT Group SA (AMADY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

AMADY

Zacks Equity Research

What Makes Aptevo Therapeutics Inc. (APVO) a New Buy Stock

Aptevo Therapeutics Inc. (APVO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

APVO

Zacks Equity Research

MFA Financial (MFA) Upgraded to Buy: Here's Why

MFA Financial (MFA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MFA

Zacks Equity Research

Chuy's (CHUY) Upgraded to Strong Buy: Here's Why

Chuy's (CHUY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CHUY

Zacks Equity Research

What Makes NTT Docomo (DCMYY) a New Strong Buy Stock

NTT Docomo (DCMYY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DCMYY

Zacks Equity Research

AXA Equitable Holdings, Inc. (EQH) Upgraded to Strong Buy: Here's Why

AXA Equitable Holdings, Inc. (EQH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

EQH

Zacks Equity Research

All You Need to Know About Aquestive Therapeutics (AQST) Rating Upgrade to Buy

Aquestive Therapeutics (AQST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AQST